2100 Manufacture of pharmaceuticals, medicinal chemical and botanical products

Code: 
2100

Selected funding rounds

Date Company Profile Round
Jun 2011 Revance Therapeutics Inc Develops and commercializes therapeutic products for treating chronic disease and age-related changes to skin and soft tissue. Venture
Jun 2011 Revance Therapeutics Inc Develops and commercializes therapeutic products for treating chronic disease and age-related changes to skin and soft tissue. Venture
Jun 2011 Revance Therapeutics Inc Develops and commercializes therapeutic products for treating chronic disease and age-related changes to skin and soft tissue. Venture
May 2011 Delenex Therapeutics AG Series A
May 2011 TetraLogic Pharmaceuticals A leader in the discovery and development of small molecule drugs called Smac mimetics for the treatment of cancers. Series C
Apr 2011 Capsugel Inc Provider of hard capsules and an innovator in drug-delivery systems. N/A
Apr 2011 Akebia Therapeutics Inc Series B
25 Mar 2011 AssureRx Health Inc Personalized medicine company specializing in pharmacogenetics Series B
10 Mar 2011 Nimbus Discovery LLC A computational technology-based drug discovery company. Seed
Mar 2011 Sonitus Medical Inc Medical device company which develops non-surgical and removable hearing and communication solution for transmitting sound through teeth. N/A
Mar 2011 Aerie Pharmaceuticals Inc Series B
Mar 2011 Arriva Medical LLC Distributor of medical supply N/A
Mar 2011 CardioFocus Inc Debt
Feb 2011 Chimerix Inc Series F
Feb 2011 SironRx Therapeutics Inc Develops regenerative therapies for the treatment of dermal wound repair N/A
Feb 2011 SironRx Therapeutics Inc Develops regenerative therapies for the treatment of dermal wound repair N/A
Feb 2011 Chimerix Inc Series F
Feb 2011 Chimerix Inc Series F
Feb 2011 Chimerix Inc Series F
Feb 2011 CardioFocus Inc Series C

Pages

Selected companies

Company type: 
Provides critical-care and hospital-based therapeutics to patients, treating physicians, and payors in the United States and internationally.
Company type: 
Developer of products that penetrate the mucosal barrier to treat a variety of severe diseases
Company type: 
Developer of small molecule therapeutics for the treatment of inflammatory disease
Subscribe to RSS - 2100 Manufacture of pharmaceuticals, medicinal chemical and botanical products